Virginia Retail Marijuana Rules: Draft Regulations, Licensing and Legal Status

Executive summary

Virginia has allowed adult possession and home growing of cannabis since July 1, 2021, but it has never had a legal retail market, and the state's release of draft retail rules in September 2026 is the clearest sign yet that one is coming. WWBT reported on September 22-23, 2026 that the state published draft rules for retail marijuana sales. Those rules turn legislative text into operating requirements for licensees: who may apply, how stores operate, what products may be sold, and how they are tested, labeled and tracked.

Virginia is an unusual case. Under legislation signed by then-Gov. Ralph Northam in 2021, adults 21 and older may possess up to one ounce and grow up to four plants per household. The statute, however, left sales for a later reenactment vote. That vote failed after Republicans took control of the governor's office and the House of Delegates in 2022. Retail bills later passed in the General Assembly but were stopped by Gov. Glenn Youngkin's veto. The result was a roughly five-year "legal possession, illegal sale" gap, which sent consumers to the illicit market, to gifting arrangements and to hemp-derived THC products.

This hub tracks the draft rules and the surrounding law. A caveat applies to the source material. The WWBT item that triggered this page is a headline-level report, and CannIntel has not independently confirmed the draft's fee schedule, license caps or comment deadlines. Those sections are marked for verification against the primary documents listed under Further reading. Operators should treat any figure not tied to a statute below as unconfirmed until it is checked against the official draft.

• Status: draft retail rules released September 2026; comment period and final adoption pending.
• Regulator: the Virginia Cannabis Control Authority (CCA), working alongside the Board of Pharmacy (medical) and VDACS (hemp).
• Federal backdrop: marijuana remains in Schedule I of the Controlled Substances Act, 21 U.S.C. § 812, unless and until rescheduling is finalized.

Why this matters

Virginia is the largest East Coast state without legal adult-use sales, with about 8.8 million residents sitting between Maryland's mature market and North Carolina's prohibition. Retail rules decide whether that population buys from licensed, tested, taxed operators or continues to buy from unregulated sources.

Consumers and patients

Adults in Virginia can legally have cannabis but have had no lawful way to buy it. Possession is legal, yet purchasing outside the medical program is not, which leaves consumers with no lab results or label verification. Medical patients, who buy through the Board of Pharmacy-regulated pharmaceutical processor system, will want to know whether adult-use competition changes product availability, pricing or the rules around their registrations.

Operators and investors

For multi-state operators (MSOs), Virginia is a large, contiguous, high-income market with a drive-time customer base in Northern Virginia, Hampton Roads and Richmond. The licensing structure, caps and vertical-integration rules will determine whether the market resembles Maryland's open competition or a tightly held oligopoly. Capital allocation decisions (real estate options, cultivation buildouts, licensing consultants) depend on those details.

Governments and public safety

Localities want clarity on zoning, local-option taxes and opt-out authority. Law enforcement and public health groups want clarity on impaired-driving enforcement, youth-access safeguards and poison-control data. Social-equity advocates want assurance that the licensing and reinvestment provisions in the 2021 law are carried into the final rules.

Scale

No reliable Virginia sales figure exists because there is no legal market to measure. A rough benchmark is Maryland, which reported approximately $1.1 billion in combined adult-use and medical sales in 2024, according to Maryland Cannabis Administration data. Scaled to Virginia's larger population, that implies a mature market in the range of $1.3-1.8 billion a year. That is CannIntel's back-of-envelope estimate, not a forecast from the state, and it depends heavily on price, tax rate and store density.

Background and history

Virginia moved from one of the East Coast's strictest cannabis regimes to legal possession in about a year, then stalled for five years on the harder question of commercial sales. The path runs through medical access, decriminalization, legalization and repeated political reversals.

1979-2018: Narrow medical carve-outs

Virginia passed a therapeutic research law in 1979 and, in 2015 and 2017, created affirmative defenses for patients using low-THC cannabidiol (CBD) and THC-A oil. In 2018 the General Assembly authorized pharmaceutical processors to produce CBD and THCA oils under Board of Pharmacy oversight. Smokable flower remained excluded, and the program stayed small and tightly controlled, with a handful of regional processors.

2018: The Farm Bill and the hemp market

The 2018 federal Farm Bill removed hemp with no more than 0.3% delta-9 THC from the Controlled Substances Act. Virginia built a hemp program under VDACS, and a retail market in hemp-derived products followed, including products containing intoxicating hemp-derived cannabinoids. That market grew in the gap left by the absence of regulated marijuana stores and remains a competitive and regulatory issue.

2020: Decriminalization

Effective July 1, 2020, Virginia replaced criminal penalties for simple possession of up to an ounce with a civil penalty of $25. The law also restricted use of the odor of marijuana as a basis for certain searches in later reforms. The same session expanded the medical program, including allowing practit